Business /

Money

United States

Will China biotech be a hard pill to swallow for US Big Pharma?

US drug makers are racing to plug looming ‘patent cliff’ revenue gaps – and increasingly they are turning to China biotechs.

Chinese AI, chip start-ups court global investors with Hong Kong listing plans

BYD ups the ante on L3 autonomous cars, begins testing for mass production

BYD has pinned its hopes on preliminary self-driving technologies to bolster its sales in mainland China.

Advertisement
Advertisement
Advertisement
Help preserve 120 years of quality journalism.
SUPPORT NOW